BNP (Brain Natriuretic Peptide) / Nesiritide

Overview

Brain Natriuretic Peptide (BNP) is a 32-amino acid cardiac-derived natriuretic peptide produced primarily by ventricular cardiomyocytes in response to increased myocardial wall stress and volume overload. It acts through natriuretic peptide receptors (NPR-A) to reduce cardiac preload and afterload, making it both a diagnostic biomarker (NT-proBNP) and a therapeutic target. Nesiritide (Natrecor), a recombinant BNP, was FDA-approved in 2001 for acutely decompensated heart failure, providing rapid preload and afterload reduction through natriuresis, vasodilation, and sympatholysis.

Mechanism of Action

BNP/nesiritide binds natriuretic peptide receptor A (NPR-A/guanylyl cyclase A), activating cGMP production. Elevated cGMP activates PKG (protein kinase G), which relaxes vascular smooth muscle (vasodilation), inhibits aldosterone secretion, reduces sympathetic nervous system tone, promotes renal natriuresis/diuresis, and suppresses cardiac fibrosis and hypertrophy. Preload reduction occurs via venodilation, afterload reduction via arteriodilation, and renal effects via enhanced natriuresis/GFR improvement.

Potential Benefits

• Acute preload and afterload reduction in decompensated heart failure
• Natriuresis and diuresis without direct tubular toxicity
• Sympatholytic activity reducing neurohormonal activation
• Diagnostic biomarker (NT-proBNP) for heart failure severity
• Anti-fibrotic and anti-hypertrophic in chronic cardiac remodeling

Research Dosage Notes

The following reflects doses used in published research studies. This is not medical advice.

Nesiritide IV: 2 mcg/kg bolus followed by 0.01 mcg/kg/min continuous infusion for up to 48 hours in decompensated heart failure.

Amino Acid Sequence

Side Effects & Safety

• Hypotension (most common, dose-limiting)
• Headache
• Nausea
• Potential worsening of renal function at high doses

Synergistic Compounds

The following compounds have been studied alongside BNP (Brain Natriuretic Peptide) / Nesiritide for potential complementary or synergistic effects:

Related Peptides

Learn More

References & Further Reading

• [object Object]
• [object Object]